Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.81 USD | +8.86% | +6.50% | +2.66% |
Business Summary
Number of employees: 484
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
T Cell Redirecting Immunotherapies
100.0
%
| 182 | 100.0 % | 58 | 100.0 % | -67.86% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 182 | 100.0 % | 58 | 100.0 % | -67.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 50 | 01/00/01 | |
Arnd Christ
DFI | Director of Finance/CFO | 57 | 01/20/01 |
Chief Tech/Sci/R&D Officer | 49 | 01/20/01 | |
Steffen Walter
COO | Chief Operating Officer | 47 | 01/20/01 |
Investor Relations Contact | - | 01/19/01 | |
Tamara Louw
HRO | Human Resources Officer | - | 01/21/01 |
Miriam Meyer
LAW | General Counsel | - | 01/09/01 |
Maria Poulada
AUD | Comptroller/Controller/Auditor | - | 01/13/01 |
Ephraim Hofsäß
AUD | Comptroller/Controller/Auditor | - | 01/19/01 |
Claudia Blattner
PRN | Corporate Officer/Principal | - | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Atieh
BRD | Director/Board Member | 70 | 01/20/01 |
Peter Chambré
CHM | Chairman | 68 | 01/12/01 |
Heather Mason
BRD | Director/Board Member | 63 | 01/20/01 |
Founder | 50 | 01/00/01 | |
Paul Carter
BRD | Director/Board Member | 63 | 01/20/01 |
Eliot Forster
BRD | Director/Board Member | 58 | 15/20/15 |
Adam Stone
BRD | Director/Board Member | 44 | 01/20/01 |
Mathias Hothum
BRD | Director/Board Member | 58 | 20/23/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 102,985,072 | 73,038,610 ( 70.92 %) | 0 | 70.92 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.66% | 1.11B | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.78% | 22.25B | |
-14.77% | 21.68B | |
-9.14% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- IMTX Stock
- Company Immatics N.V.